Alcoa Shares Drop 2.5% After Price Target Drop, EMC, Medtronic Monsanto Show Strength
Following this morning’s impressive jobs data, traders and investors continued seeking out good stocks in the marketplace. The Dow Jones Industrial Average (NYSEARCA:DIA) is down 39 points, or .32%, to 12,375. The S&P 500 (NYSEARCA:SPY) is down 1.77 points, or .14%, to 1,279, and the Nasdaq (NASDAQ:QQQ) is up 3 points, or .12%, to 2,672. The following stocks are reacting to the evaluations of analysts in the brokerage community:
Blaming the company’s falling revenue, Deutsche Bank reduced its price target for Alcoa, Inc. (NYSE:AA) to $10 from $12. Deutsche Bank maintains a Hold rating for the stock, in advance of the Q4 earnings report to be issued January 9.
EMC Corporation (NYSE:EMC) is expected to report stronger than projected Q4 results, according to ThinkEquity. The firm believes that EMC’s Q4 results will be aided by strength in virtual information. ThinkEquity expects that EMC’s 2012 margin and revenue outlook will be prudent, and holds to a Buy rating.
Susquehanna elevated its price target on agriculture behemoth Monsanto (NYSE:MON) from $85 to $90 after better than expected Q1 results were reported. Susquehanna based this on reduced risk around new product releases and an improved 2012 earnings outlook. Shares are rated Positive.
According to checks by Bernstein, ICD declines by Medtronic are stabilizing. Bernstein’s research lead to thinking that the U.S. ICD market stabilized in Q4, leading into a better 2012. Medtronic is Bernstein’s top pick, with an Outperform rating.
To contact the reporter on this story: Brooke Edge at email@example.com
To contact the editor responsible for this story: Damien Hoffman at firstname.lastname@example.org